Li, C., Zhang, E., Yu, R., Yuan, B., Yang, Y., Zeng, Z., & Huang, H. Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC. Elsevier.
Chicago Style (17th ed.) CitationLi, Chenxuan, En-di Zhang, Rui Yu, Bo Yuan, Yunxin Yang, Zhong Zeng, and Hanfei Huang. Comprehensive Multi-omics Analysis Showed That CDC6 Is a Potential Prognostic and Immunotherapy Biomarker for Multiple Cancer Types Including HCC. Elsevier.
MLA (9th ed.) CitationLi, Chenxuan, et al. Comprehensive Multi-omics Analysis Showed That CDC6 Is a Potential Prognostic and Immunotherapy Biomarker for Multiple Cancer Types Including HCC. Elsevier.
Warning: These citations may not always be 100% accurate.